首页> 美国卫生研究院文献>Journal of Applied Clinical Medical Physics >Evaluation of hybrid inverse planning and optimization (HIPO) algorithm for optimization in real‐time high‐dose‐rate (HDR) brachytherapy for prostate
【2h】

Evaluation of hybrid inverse planning and optimization (HIPO) algorithm for optimization in real‐time high‐dose‐rate (HDR) brachytherapy for prostate

机译:评估混合逆向计划和优化(HIPO)算法以优化实时大剂量(HDR)前列腺癌的近距离放射治疗

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

The purpose of this study is to investigate the effectiveness of the HIPO planning and optimization algorithm for real‐time prostate HDR brachytherapy. This study consists of 20 patients who underwent ultrasound‐based real‐time HDR brachytherapy of the prostate using the treatment planning system called Oncentra Prostate (SWIFT version 3.0). The treatment plans for all patients were optimized using inverse dose‐volume histogram–based optimization followed by graphical optimization (GRO) in real time. The GRO is manual manipulation of isodose lines slice by slice. The quality of the plan heavily depends on planner expertise and experience. The data for all patients were retrieved later, and treatment plans were created and optimized using HIPO algorithm with the same set of dose constraints, number of catheters, and set of contours as in the real‐time optimization algorithm. The HIPO algorithm is a hybrid because it combines both stochastic and deterministic algorithms. The stochastic algorithm, called simulated annealing, searches the optimal catheter distributions for a given set of dose objectives. The deterministic algorithm, called dose‐volume histogram–based optimization (DVHO), optimizes three‐dimensional dose distribution quickly by moving straight downhill once it is in the advantageous region of the search space given by the stochastic algorithm. The PTV receiving 100% of the prescription dose (V100) was 97.56% and 95.38% with GRO and HIPO, respectively. The mean dose (Dmean) and minimum dose to 10% volume (D10) for the urethra, rectum, and bladder were all statistically lower with HIPO compared to GRO using the student pair t‐test at 5% significance level. HIPO can provide treatment plans with comparable target coverage to that of GRO with a reduction in dose to the critical structures.PACS number: 87.55.‐X
机译:本研究的目的是研究HIPO计划和优化算法对实时前列腺HDR近距离放射治疗的有效性。这项研究由20名患者组成,这些患者使用称为Oncentra Prostate(SWIFT 3.0版)的治疗计划系统进行了基于超声的前列腺实时HDR近距离放射治疗。使用基于剂量-体积直方图的反向优化,然后实时进行图形优化(GRO),优化了所有患者的治疗计划。 GRO是逐片对等剂量线的手动操作。计划的质量在很大程度上取决于计划者的专业知识和经验。稍后检索所有患者的数据,并使用HIPO算法以与实时优化算法相同的一组剂量约束,导管数量和轮廓集来创建和优化治疗计划。 HIPO算法是一种混合算法,因为它结合了随机算法和确定性算法。随机算法称为模拟退火,它针对给定的剂量目标集搜索最佳导管分布。确定性算法称为基于剂量-体积直方图的优化(DVHO),一旦它位于随机算法给出的搜索空间的有利区域内,就可以通过直接向下移动来快速优化三维剂量分布。 PTV接收100%的处方剂量( V 100 )对于GRO和HIPO分别为97.56%和95.38%。平均剂量(<数学xmlns:mml =“ http://www.w3.org/1998/Math/MathML” id =“ nlm-math-2”溢出=“ scroll”> D 平均值 ),最小剂量应达到10%的体积( D 10 <使用学生配对t检验(显着性水平为5%),HIPO与GRO相比,尿道,直肠和膀胱在统计学上均较低。 HIPO可以为治疗计划提供与GRO相当的靶标覆盖范围,同时减少关键结构的剂量.PACS编号:87.55.-X

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号